Chromophobe renal cell carcinoma with prolonged response to sequential sunitinib and everolimus.
James M G
JM
Larkin
Rosalie A
RA
Fisher
Lisa M
LM
Pickering
S Aslam
SA
Sohaib
Marwan
M
Ghosn
Tim
T
Christmas
Ruth L M
RL
Cordiner
Martin E
ME
Gore
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000473:pathology; D000068338:Everolimus; D006801:Humans; D007211:Indoles / Q000008:administration & dosage; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011758:Pyrroles / Q000008:administration & dosage; D020123:Sirolimus / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077210:Sunitinib; D016896:Treatment Outcome
D007211:Indoles; D011758:Pyrroles; D000068338:Everolimus; D000077210:Sunitinib; D020123:Sirolimus